• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞来源的外泌体在治疗骨关节炎中的作用。

Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis.

机构信息

East Hospital, Tongji University School of Medicine, Shanghai, China.

Department of Orthopaedics, Shanghai Pudong Hospital, Fudan University, Shanghai, China.

出版信息

Cell Reprogram. 2020 Jun;22(3):107-117. doi: 10.1089/cell.2019.0098. Epub 2020 May 4.

DOI:10.1089/cell.2019.0098
PMID:32364765
Abstract

Exosomes are small extracellular vesicles (EVs) with a diameter of 50-150 nm that play important roles in cell-to-cell communication through transportation of proteins, microRNAs, lncRNAs, and mRNAs. Some components, such as miRNAs, have been proven to be involved in inflammation regulation. Osteoarthritis (OA) is a progressive disease resulting in articular cartilage degeneration and subchondral bone deficiency. Complicated relationships between the breakdown of extracellular matrix and inflammation make it difficult to recover thoroughly. Current studies reported that exosomes secreted by mesenchymal stem cells (MSCs) can change disease evolution and protect the cartilage matrix in OA. In addition, exosomes obtained from human adipose derived stem cells downregulate inflammation and oxidative stress, which might mediate antisenescence in OA. The goal of this review is to describe and summarize the role of mesenchymal stem cell (MSC)-derived exosomes in OA, focusing on their potential mechanism and possible therapeutic strategies.

摘要

外泌体是直径为 50-150nm 的小型细胞外囊泡,通过运输蛋白质、microRNAs、lncRNAs 和 mRNAs 在细胞间通讯中发挥重要作用。一些成分,如 miRNAs,已被证明参与炎症调节。骨关节炎 (OA) 是一种进行性疾病,导致关节软骨退化和软骨下骨缺损。细胞外基质的破坏与炎症之间复杂的关系使得其难以彻底恢复。目前的研究表明,间充质干细胞 (MSCs) 分泌的外泌体可以改变疾病的进展并保护 OA 中的软骨基质。此外,从人脂肪来源干细胞中获得的外泌体可下调炎症和氧化应激,这可能介导 OA 中的抗衰老。本综述的目的是描述和总结间充质干细胞 (MSC) 衍生的外泌体在 OA 中的作用,重点关注其潜在的机制和可能的治疗策略。

相似文献

1
Roles of Exosomes from Mesenchymal Stem Cells in Treating Osteoarthritis.间充质干细胞来源的外泌体在治疗骨关节炎中的作用。
Cell Reprogram. 2020 Jun;22(3):107-117. doi: 10.1089/cell.2019.0098. Epub 2020 May 4.
2
miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis.富含 miR-100-5p 的骨关节炎来源的髌下脂肪垫间充质干细胞来源的外泌体通过抑制 mTOR 保护关节软骨并改善步态异常。
Biomaterials. 2019 Jun;206:87-100. doi: 10.1016/j.biomaterials.2019.03.022. Epub 2019 Mar 20.
3
The role and therapeutic potential of MSC-derived exosomes in osteoarthritis.间充质干细胞来源的外泌体在骨关节炎中的作用和治疗潜力。
Arch Biochem Biophys. 2021 Oct 15;710:109002. doi: 10.1016/j.abb.2021.109002. Epub 2021 Aug 2.
4
Extracellular Vesicles from Mesenchymal Stem Cells as Potential Treatments for Osteoarthritis.间充质干细胞来源的细胞外囊泡作为骨关节炎治疗的潜在方法。
Cells. 2021 May 22;10(6):1287. doi: 10.3390/cells10061287.
5
Therapeutic effects of bone marrow mesenchymal stem cells-derived exosomes on osteoarthritis.骨髓间充质干细胞来源的外泌体对骨关节炎的治疗作用。
J Cell Mol Med. 2021 Oct;25(19):9281-9294. doi: 10.1111/jcmm.16860. Epub 2021 Aug 27.
6
Cartilage Repair by Mesenchymal Stem Cell-Derived Exosomes: Preclinical and Clinical Trial Update and Perspectives.间质干细胞衍生外泌体修复软骨:临床前和临床试验更新及展望。
Adv Exp Med Biol. 2021;1326:73-93. doi: 10.1007/5584_2021_625.
7
Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review).单细胞测序、遗传学和表观遗传学揭示骨关节炎中间充质干细胞衰老(综述)。
Int J Mol Med. 2024 Jan;53(1). doi: 10.3892/ijmm.2023.5326. Epub 2023 Nov 8.
8
Evaluation of Extracellular Vesicles from Adipose Tissue-Derived Mesenchymal Stem Cells in Primary Human Chondrocytes from Patients with Osteoarthritis.评估来源于脂肪组织间充质干细胞的细胞外囊泡对骨关节炎患者原代人软骨细胞的作用。
Methods Mol Biol. 2021;2269:221-231. doi: 10.1007/978-1-0716-1225-5_15.
9
Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?间质干细胞衍生的外泌体:骨关节炎的一种新治疗方法?
Stem Cell Res Ther. 2019 Nov 21;10(1):340. doi: 10.1186/s13287-019-1445-0.
10
Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A.来源于 miR-92a-3p 过表达的人骨髓间充质干细胞的外泌体通过靶向 WNT5A 增强软骨生成并抑制软骨降解。
Stem Cell Res Ther. 2018 Sep 26;9(1):247. doi: 10.1186/s13287-018-1004-0.

引用本文的文献

1
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases.间充质干细胞衍生的外泌体作为一种用于炎症性疾病的合理免疫调节治疗工具。
Front Cell Dev Biol. 2025 Mar 10;13:1563427. doi: 10.3389/fcell.2025.1563427. eCollection 2025.
2
Potential and challenges of utilizing exosomes in osteoarthritis therapy (Review).利用外泌体进行骨关节炎治疗的潜力与挑战(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5484. Epub 2025 Jan 10.
3
Synovial mesenchymal stem cell-derived exosomal miR-485-3p relieves cartilage damage in osteoarthritis by targeting the NRP1-mediated PI3K/Akt pathway: Exosomal miR-485-3p relieves cartilage damage.
滑膜间充质干细胞来源的外泌体miR-485-3p通过靶向NRP1介导的PI3K/Akt通路减轻骨关节炎中的软骨损伤:外泌体miR-485-3p减轻软骨损伤。
Heliyon. 2024 Jan 3;10(2):e24042. doi: 10.1016/j.heliyon.2024.e24042. eCollection 2024 Jan 30.
4
Adipose stem cells in tissue regeneration and repair: From bench to bedside.组织再生与修复中的脂肪干细胞:从实验台到病床边
Regen Ther. 2023 Oct 11;24:547-560. doi: 10.1016/j.reth.2023.09.014. eCollection 2023 Dec.
5
Exosomes derived from miR-338-3p-modified adipose stem cells inhibited inflammation injury of chondrocytes via targeting RUNX2 in osteoarthritis.来源于 miR-338-3p 修饰的脂肪干细胞来源的外泌体通过靶向 RUNX2 抑制骨关节炎软骨细胞的炎症损伤。
J Orthop Surg Res. 2022 Dec 26;17(1):567. doi: 10.1186/s13018-022-03437-2.
6
The Effectiveness and Safety of Mesenchymal Stem Cells in the Treatment of Osteoarthritis: A Systematic Review and Meta-analysis of 28 Randomized Controlled Trials.间充质干细胞治疗骨关节炎的有效性和安全性:28项随机对照试验的系统评价和荟萃分析
Stem Cells Int. 2022 Oct 12;2022:6151866. doi: 10.1155/2022/6151866. eCollection 2022.
7
Impact of Cardiovascular Diseases on Ischemic Stroke Outcomes.心血管疾病对缺血性脑卒中结局的影响。
J Integr Neurosci. 2022 Jul 26;21(5):138. doi: 10.31083/j.jin2105138.
8
Exosomal miR-221-3p Derived from Bone Marrow Mesenchymal Stem Cells Alleviates Asthma Progression by Targeting FGF2 and Inhibiting the ERK1/2 Signaling Pathway.源自骨髓间充质干细胞的外泌体miR-221-3p通过靶向FGF2并抑制ERK1/2信号通路减轻哮喘进展。
Evid Based Complement Alternat Med. 2022 Aug 10;2022:5910874. doi: 10.1155/2022/5910874. eCollection 2022.
9
Evaluation of Adipose Cell-Based Therapies for the Treatment of Thumb Carpometacarpal Joint Osteoarthritis.基于脂肪细胞的治疗方法治疗拇指腕掌关节骨关节炎的评估。
Biomolecules. 2022 Mar 20;12(3):473. doi: 10.3390/biom12030473.
10
Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics.利用组织衍生的细胞外囊泡进行骨关节炎治疗学研究。
Theranostics. 2022 Jan 1;12(1):207-231. doi: 10.7150/thno.62708. eCollection 2022.